Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.


The derivation of embryonic stem cells (hESC) from human embryos a decade ago started a new era in perspectives for cell therapy as well as understanding human development and disease. More recently, reprogramming of somatic cells to an embryonic stem cell-like state (induced pluripotent stem cells, iPS) presented a new milestone in this area, making it… (More)
DOI: 10.1002/jcb.22164

1 Figure or Table


  • Presentations referencing similar topics